-
2023
- Sep 19, 2023 Folia Health Announces Distinguished Founding Members for its Scientific Advisory Council Sep 19, 2023
- Sep 5, 2023 Folia Health Reinforces Commitment to Autoimmune and Neurological Conditions: Announcing the Expansion of Multiple Sclerosis, Huntington's Disease, and Myasthenia Gravis User Cohorts Sep 5, 2023
- Jun 2, 2023 Folia Health joins the Cancer Moonshot’s CancerX Public-Private Partnership as a Founding Member Jun 2, 2023
- May 30, 2023 Folia Health launches user-led research program, the Canopy Series May 30, 2023
- 2022
-
2021
- Sep 13, 2021 Wyss Institute announces Industrial Participant Program (IPP) to accelerate the development of urgently needed diagnostic capabilities Sep 13, 2021
- Jun 2, 2021 First-of-Its-Kind Study Uses Smartphone to Track Cystic Fibrosis in Real Life Jun 2, 2021
- May 4, 2021 Soleno Therapeutics Announces Presentation of Positive Behavioral Data from Ongoing Extension Study of DCCR for Treatment of Prader-Willi Syndrome May 4, 2021
-
2019
- Sep 13, 2019 Folia Health Launches the First Data Dividends Program to Recognize the Power of Patient and Caregiver Knowledge Sep 13, 2019
- Jun 21, 2019 Folia Health Announces Primary Immunodeficiencies (PI) as Second Condition of Focus at the IDF National Conference Jun 21, 2019
- Apr 1, 2019 Folia Health Announces New Provider Program Apr 1, 2019
Keep reading: